116 related articles for article (PubMed ID: 26376220)
1. Different patterns of 5-HT receptor and transporter dysfunction in neuropsychiatric disorders--a comparative analysis of in vivo imaging findings.
Nikolaus S; Müller HW; Hautzel H
Rev Neurosci; 2016 Jan; 27(1):27-59. PubMed ID: 26376220
[TBL] [Abstract][Full Text] [Related]
2. Acute anxiety disorder, major depressive disorder, bipolar disorder and schizophrenia are related to different patterns of nigrostriatal and mesolimbic dopamine dysfunction.
Nikolaus S; Mamlins E; Hautzel H; Müller HW
Rev Neurosci; 2019 May; 30(4):381-426. PubMed ID: 30269107
[TBL] [Abstract][Full Text] [Related]
3. Neuroreceptor imaging in depression.
Savitz JB; Drevets WC
Neurobiol Dis; 2013 Apr; 52():49-65. PubMed ID: 22691454
[TBL] [Abstract][Full Text] [Related]
4. Focus on GABA(A) receptor function. A comparative analysis of in vivo imaging studies in neuropsychiatric disorders.
Nikolaus S; Hautzel H; Müller HW
Nuklearmedizin; 2014; 53(6):227-37. PubMed ID: 25483111
[TBL] [Abstract][Full Text] [Related]
5. Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder.
Cannon DM; Ichise M; Rollis D; Klaver JM; Gandhi SK; Charney DS; Manji HK; Drevets WC
Biol Psychiatry; 2007 Oct; 62(8):870-7. PubMed ID: 17678634
[TBL] [Abstract][Full Text] [Related]
6. Neither cortisol nor brain-derived neurotrophic factor is associated with serotonin transporter in bipolar disorder.
Chou YH; Lirng JF; Hsieh WC; Chiu YC; Tu YA; Wang SJ
Eur Neuropsychopharmacol; 2016 Feb; 26(2):280-287. PubMed ID: 26706694
[TBL] [Abstract][Full Text] [Related]
7. Decreased brain serotonin transporter binding in the euthymic state of bipolar I but not bipolar II disorder: a SPECT study.
Chou YH; Wang SJ; Lin CL; Mao WC; Lee SM; Liao MH
Bipolar Disord; 2010 May; 12(3):312-8. PubMed ID: 20565438
[TBL] [Abstract][Full Text] [Related]
8. Association of thalamic serotonin transporter and interleukin-10 in bipolar I disorder: a SPECT study.
Hsu JW; Lirng JF; Wang SJ; Lin CL; Yang KC; Liao MH; Chou YH
Bipolar Disord; 2014 May; 16(3):241-8. PubMed ID: 24372850
[TBL] [Abstract][Full Text] [Related]
9. Brain serotonin transporter binding in depressed patients with bipolar disorder using positron emission tomography.
Oquendo MA; Hastings RS; Huang YY; Simpson N; Ogden RT; Hu XZ; Goldman D; Arango V; Van Heertum RL; Mann JJ; Parsey RV
Arch Gen Psychiatry; 2007 Feb; 64(2):201-8. PubMed ID: 17283287
[TBL] [Abstract][Full Text] [Related]
10. Cerebral blood flow, metabolic, receptor, and transporter changes in bipolar disorder: the role of PET and SPECT studies.
Gonul AS; Coburn K; Kula M
Int Rev Psychiatry; 2009; 21(4):323-35. PubMed ID: 20374147
[TBL] [Abstract][Full Text] [Related]
11. Serotonin 2A receptor, serotonin transporter and dopamine transporter alterations in dogs with compulsive behaviour as a promising model for human obsessive-compulsive disorder.
Vermeire S; Audenaert K; De Meester R; Vandermeulen E; Waelbers T; De Spiegeleer B; Eersels J; Dobbeleir A; Peremans K
Psychiatry Res; 2012 Jan; 201(1):78-87. PubMed ID: 22285716
[TBL] [Abstract][Full Text] [Related]
12. Cortical and subcortical 5-HT2A receptor binding in neuroleptic-naive first-episode schizophrenic patients.
Erritzoe D; Rasmussen H; Kristiansen KT; Frokjaer VG; Haugbol S; Pinborg L; Baaré W; Svarer C; Madsen J; Lublin H; Knudsen GM; Glenthoj BY
Neuropsychopharmacology; 2008 Sep; 33(10):2435-41. PubMed ID: 18288096
[TBL] [Abstract][Full Text] [Related]
13. Effects of olanzapine and betahistine co-treatment on serotonin transporter, 5-HT2A and dopamine D2 receptor binding density.
Lian J; Huang XF; Pai N; Deng C
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():62-8. PubMed ID: 23994047
[TBL] [Abstract][Full Text] [Related]
14. Different patterns of dopaminergic and serotonergic dysfunction in manic, depressive and euthymic phases of bipolar disorder.
Nikolaus S; Müller HW; Hautzel H
Nuklearmedizin; 2017; 56(5):191-200. PubMed ID: 29533425
[TBL] [Abstract][Full Text] [Related]
15. Increased serotonin and dopamine transporter binding in psychotropic medication-naive patients with generalized social anxiety disorder shown by 123I-beta-(4-iodophenyl)-tropane SPECT.
van der Wee NJ; van Veen JF; Stevens H; van Vliet IM; van Rijk PP; Westenberg HG
J Nucl Med; 2008 May; 49(5):757-63. PubMed ID: 18413401
[TBL] [Abstract][Full Text] [Related]
16. Aggression in bipolar II disorder and its relation to the serotonin transporter.
Chou YH; Lin CL; Wang SJ; Lirng JF; Yang KC; Chien Chang A; Liao MH
J Affect Disord; 2013 May; 147(1-3):59-63. PubMed ID: 23123132
[TBL] [Abstract][Full Text] [Related]
17. Chronic buspirone treatment decreases 5-HT1B receptor densities and the serotonin transporter but increases the density of 5-HT2A receptors in the bulbectomized rat model of depression: an autoradiographic study.
Sato H; Skelin I; Diksic M
Brain Res; 2010 Jul; 1345():28-44. PubMed ID: 20501324
[TBL] [Abstract][Full Text] [Related]
18. Serotonin: imaging findings in eating disorders.
Bailer UF; Kaye WH
Curr Top Behav Neurosci; 2011; 6():59-79. PubMed ID: 21243470
[TBL] [Abstract][Full Text] [Related]
19. HTR2A-1438A/G polymorphism influences the risk of schizophrenia but not bipolar disorder or major depressive disorder: a meta-analysis.
Gu L; Long J; Yan Y; Chen Q; Pan R; Xie X; Mao X; Hu X; Wei B; Su L
J Neurosci Res; 2013 May; 91(5):623-33. PubMed ID: 23404241
[TBL] [Abstract][Full Text] [Related]
20. Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography.
Cannon DM; Ichise M; Fromm SJ; Nugent AC; Rollis D; Gandhi SK; Klaver JM; Charney DS; Manji HK; Drevets WC
Biol Psychiatry; 2006 Aug; 60(3):207-17. PubMed ID: 16875929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
